Financing ·
Radiopharm Theranostics Limited issued 384,493,800 ordinary shares on July 28, 2026, as part of a placement announced…
RADXRadiopharm Theranostics Ltd
Radiopharm Theranostics Limited issued 384,493,800 ordinary shares on July 28, 2026, as part of a placement announced on July 24, 2026. The securities were issued at a price of AUD 0.015 per share, representing 1,281,646 American Depositary Shares (ADS). This issuance brings the total issued capital of ordinary shares to 3,928,709,960. The company also disclosed additional securities yet to be issued to complete the transaction, including 448,839,531 ordinary shares and various options and warrants. Radiopharm Theranostics Limited operates in the biotechnology industry, specializing in the development of radiopharmaceuticals for theranostic applications.